BONE BIOLOGICS CORPORATION (BBLGW) Operating income 2016–2025
BONE BIOLOGICS CORPORATION (BBLGW) annual operating income history from SEC filings — each fiscal year as reported.
-$3.2MFY2025 · since FY2016: -$20.4M → -$3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.2M | +23.3% |
| FY2024 | -$4.2M | +55.3% |
| FY2023 | -$9.4M | -157.2% |
| FY2022 | -$3.7M | -232.3% |
| FY2021 | -$1.1M | -33.7% |
| FY2020 | -$825,014 | +66.3% |
| FY2019 | -$2.4M | +12.3% |
| FY2018 | -$2.8M | -6.3% |
| FY2017 | -$2.6M | +87.1% |
| FY2016 | -$20.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice